The Changing Paradigm of Regulatory Submissions:
Embracing Automation, Gen AI, and Innovation for Faster Approvals

This informative webinar is aimed to be forward-looking, discuss the potential promises of emerging technological tools in expediting and radically changing submission preparation, pinpoint potential challenges and brainstorm resolutions.

The current landscape of regulatory submissions is weighed down by the sheer volume of documentation required, complex guidelines and repetitive information across documents. It also involves the painstaking, cumbersome writing styles and processes necessitating multiple rounds of reviews on the same content across documents, increasing costs and jeopardizing efficiency and quality, thereby adding to the already long cycle times of drugs from bench to bedside.

In the regulatory writing sphere, generative artificial intelligence (AI), automation, structured authoring, collaborative authoring and lean writing are slowly making their way into how work is accomplished. These tools in turn will lead to fast, efficient and robust filing of marketing authorization applications. Thus, there is a possibility of a paradigm shift in the field, a change that is all radiant and promising, albeit requiring wise use of these applications.

As these concepts and styles are incorporated into how submissions are approached, the following changes are expected in the field:

• Radically enhance the speed and quality of the submission documents
• Free up highly skilled and qualified medical writers from redundant transactional jobs and engage them more “intelligently” — to program the automation drivers and generative AI tools efficiently
• Bring forward approval timelines and thus increase the reach of drugs to waiting patients faster
• Help shape the regulatory landscape allowing for innovation with AI

Register for this webinar today to gain insights into the potential promise of emerging AI tools in expediting and radically changing how regulatory submissions are prepared.